Clinical Trials Directory

Trials / Completed

CompletedNCT01279265

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Crying, Intestinal Microbiota, and Intestinal Inflammation in Infants With Colic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
3 Weeks – 3 Months
Healthy volunteers
Accepted

Summary

This study will compare 2 currently marketed formulas in healthy full term babies: Nutramigen A+ (a hypoallergenic formula) and Nutramigen-Enflora (hypoallergenic formula with Lactobacillus GG (LGG)) during 3 months of formula feeding. The investigators' aims are to compare 3 outcomes in these babies: (1) normal baby crying time; (2) the composition of intestinal microbiota (bacteria in the stool); and (3) a lab test which measures the number of white blood cells in the large intestine (fecal calprotectin). The investigators predict that LGG supplementation (Nutramigen-Enflora) will facilitate its establishment as an important component of the neonatal intestinal microbial community and reduce fecal calprotectin.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNutramigen with EnfloraHypoallergenic formula with probiotic - Lactobacillus GG
DIETARY_SUPPLEMENTNutramigen A+Hypoallergenic formula without lactobacillus

Timeline

Start date
2011-09-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2011-01-19
Last updated
2015-11-11
Results posted
2015-11-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01279265. Inclusion in this directory is not an endorsement.